Patents by Inventor Naresh Kumar

Naresh Kumar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AZABICYCLIC MUSCARINIC RECEPTOR ANTAGONISTS
    Publication number: 20100016400
    Abstract: The present invention generally relates to muscarinic receptor antagonists, which are useful for treating various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to processes for preparing compounds described herein, pharmaceutical compositions containing the disclosed compounds, and the methods for treating diseases mediated through muscarinic receptors.
    Type: Application
    Filed: November 18, 2005
    Publication date: January 21, 2010
    Inventors: Naresh Kumar, Mohammad Salman, Kirandeep Kaur, Anita Mehta, Sudershan K. Arora, Anita Chugh
  • MUSCARINIC RECEPTOR ANTAGONISTS
    Publication number: 20090326004
    Abstract: The present invention relates generally to muscarinic receptor antagonist, which are useful, among other uses, for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to the process for the preparation of disclosed compounds, pharmaceutical compositions containing the disclosed compounds and the method for treating diseases mediated through muscarinic receptors. Also provided herein are pharmaceutical composition comprising one or more muscarinic receptor antagonists and at least one other active ingredients include, but are not limited to, corticosteroids, beta agonists, leukotriene antagonists, 5-lipoxygenase inhibitors, anti-histamines, antitussives, dopamine receptor antagonists, chemokine inhibitors, p38 MAP Kinase inhibitors, and PDE-IV inhibitors.
    Type: Application
    Filed: May 28, 2009
    Publication date: December 31, 2009
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Naresh KUMAR, Jitendra A. SATTIGERI, Shelly AERON, Malvika GARG, Abhijit RAY, Suman GUPTA, Shivani MALHOTRA, Raj Kumar SHIRUMALLA
  • SYSTEM AND METHOD FOR BILLING SYSTEM INTERFACE FAILOVER RESOLUTION
    Publication number: 20090319596
    Abstract: A determination is made whether a first application server of a group of N application servers, N being at least two, is a coordinator of the group. Responsive to determining that the first application server is the coordinator of the group, a connection to a billing system is established, via a terminal server, by the first application server. A determination is made whether a second application server of the group of N application servers is the coordinator of the group. Responsive to determining that the second application server is not the coordinator of the group, a periodic check is made whether the second application server of the group of N application servers is the coordinator of the group. The second application server may later be determined to be the coordinator of the group, when the first server experiences difficulty.
    Type: Application
    Filed: June 18, 2008
    Publication date: December 24, 2009
    Applicant: Time Warner Cable Inc
    Inventors: Naresh Kumar, Robert Perry
  • Antimicrobial coatings
    Patent number: 7625579
    Abstract: The present invention provides a substrate having a plurality of immobilised furanone moieties associated with at least part of a surface of the substrate. The invention also relates to articles consisting of or comprising such a substrate.
    Type: Grant
    Filed: April 10, 2001
    Date of Patent: December 1, 2009
    Assignee: Unisearch Limited
    Inventors: Roger Read, Naresh Kumar, Mark Wilcox, Hua Zhu, Hnas Griesser, Ben Muir, Helmut Thissen, Tim Hughes
  • COMPOSITIONS AND THERAPEUTIC METHODS INVOLVING ISOFLAVONES AND ANALOGUES THEREOF
    Publication number: 20090233999
    Abstract: Isoflavone compounds and analogues thereof, compositions containing same and therapeutic methods of treatment involving same are described.
    Type: Application
    Filed: November 6, 2008
    Publication date: September 17, 2009
    Applicant: NOVOGEN RESEARCH PTY LTD
    Inventors: ANDREW HEATON, NARESH KUMAR, GRAHAM EDMUND KELLY, ALAN HUSBAND
  • Azabicyclo derivatives as muscarinic receptor antagonists
    Patent number: 7544708
    Abstract: This invention generally relates to muscarinic receptor antagonists which are useful, among other uses, for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. Specifically, the invention relates to derivatives of azabicyclo compounds, including, for example, 6-substituted azabicyclo[3.1.0] hexanes, and 2,4,6-trisubstituted derivatives. The invention also relates to pharmaceutical compositions containing the compounds and the methods of treating the diseases mediated through muscarinic receptors.
    Type: Grant
    Filed: April 11, 2003
    Date of Patent: June 9, 2009
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Mohammad Salman, Anita Mehta, Pakala Kumara Savithru Sarma, Shankar Jayram Shetty, Sankaranarayanan Dharmarajan, Naresh Kumar, Arundutt Vishwanatham Silamkoti, Anita Chugh
  • MUSCARINIC RECEPTOR ANTAGONISTS
    Publication number: 20090137623
    Abstract: The present invention relates to muscarinic receptor modulators, specifically, 7-oxo-2-azabicyclo[2.2.1]heptanes of formula (I) which are useful for the treatment of various diseases and conditions, for example, Alzheimer's disease, glaucoma, psychosis, particularly schizophrenia or schizophreniform conditions, mania, pain, bipolar disorder, depression, sleeping disorders, epilepsy, gastrointestinal motility disorders, urinary incontinence, and cognition enhancement.
    Type: Application
    Filed: January 2, 2007
    Publication date: May 28, 2009
    Inventors: Naresh Kumar, Ian Anthony Cliffe, Mohammad Salman, Venkata P. Palle, Kirandeep Kaur, Yogesh D. Shejul, Anita Chugh, Suman Gupta, Abhijit Ray, Shivani Malhotra, Raj Kumar Shirumalla
  • 3-AZABICYCLOOCTANE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS
    Publication number: 20090131410
    Abstract: Provided are muscarinic receptor antagonists, which can be useful in treating various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. Also provided are processes for preparing compounds described herein, pharmaceutical compositions thereof, and methods for treating diseases mediated through muscarinic receptors.
    Type: Application
    Filed: October 5, 2006
    Publication date: May 21, 2009
    Inventors: Naresh Kumar, Kirandeep Kaur, Suman Gupta, Anita Chugh, Mohammad Salman, Raj Kumar Shirumalla, Shivani Malhotra
  • MUSCARINIC RECEPTOR ANTAGONISTS
    Publication number: 20090105221
    Abstract: This present invention generally relates to muscarinic receptor antagonists of Formula (I), which are useful, among other uses, for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to the process for the prepration of disclosed compounds, pharmaceutical compositions containing the disclosed compounds, and the methods for treating diseases mediated through muscarinic receptors.
    Type: Application
    Filed: September 28, 2005
    Publication date: April 23, 2009
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Mohammad Salman, Pakala Kumara Savithru Sarma, Arani Pal, Anita Chugh, Suman Gupta, Venkata P. Palle, Naresh Kumar, Kirandeep Kaur
  • PROCESS FOR THE PREPARATION OF POLYMORPHIC FORMS OF CLOPIDOGREL HYDROGEN SULFATE
    Publication number: 20090099363
    Abstract: The present invention relates to a novel process for the preparation of polymorphic forms of clopidogrel hydrogen sulfate, namely methyl(+)-(S)-?-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate hydrogen sulfate of formula (I). Particularly the present invention relates to the process for the preparation of form (I) and amorphous clopidogrel hydrogen sulfate.
    Type: Application
    Filed: April 25, 2007
    Publication date: April 16, 2009
    Inventors: Saxena Rahul, Verma Naresh Kumar, Srinivasan Chidambaram Venkateswaran, Wadhwa Lalit
  • Bioavailability/bioefficacy enhancing activity of and extracts and fractions thereof
    Patent number: 7514105
    Abstract: The present invention relates to a bioenhancing/bioavailability-facilitating composition comprising: an effective amount of an extract and/or at least one bioactive fraction from Cuminum cyminum; one or more additive selected from drugs, nutrients, vitamins, nutraceuticals, herbal drugs/products, micro nutrients, antioxidants along with pharmaceuticaly acceptable additives/excipient, and optionally, an effective amount of piperine or extract/fraction of piper nigrum or piper longum; and a process for the preparation of such extracts and active fractions from plant Cuminum cyminum.
    Type: Grant
    Filed: February 23, 2006
    Date of Patent: April 7, 2009
    Assignee: Council of Scientific and Industrial Research
    Inventors: Ghulam Nabi Qazi, Kasturi Lal Bedi, Rakesh Kamal Johri, Manoj Kumar Tikoo, Ashok Kumar Tikoo, Subhash Chander Sharma, Sheikh Tasaduq Abdullah, Om Parkash Suri, Bishan Datt Gupta, Krishan Avtar Suri, Naresh Kumar Satti, Ravi Kant Khajuria, Surjit Singh, Anamika Khajuria, Bal Krishan Kapahi
  • Regulators of Bacterial Signalling Pathways
    Publication number: 20090048461
    Abstract: The present invention provides a method for the preparation of compounds of formula (II). The invention also provides novel compounds of formula (II) and their use in medical, scientific and/or biological applications.
    Type: Application
    Filed: June 21, 2005
    Publication date: February 19, 2009
    Applicant: Biosignal Limited
    Inventor: Naresh Kumar
  • Compositions and therapeutic methods involving isoflavones and analogues thereof
    Patent number: 7488494
    Abstract: Isoflavone compounds are described and recommended as therapeutic agents. Exemplified and preferred compounds are (a). Indications show compounds have good competitive binding to estrogen receptors.
    Type: Grant
    Filed: November 7, 2003
    Date of Patent: February 10, 2009
    Assignee: Novogen Research Pty Ltd.
    Inventors: Andrew Heaton, Naresh Kumar, Graham Edmund Kelly, Alan Husband
  • 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists
    Patent number: 7488748
    Abstract: This invention generally relates to derivatives of 3,6 disubstituted azabicyclo hexanes. The compounds of this invention can function as muscarinic receptor antagonists and can be used for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to pharmaceutical compositions containing the compounds of the present invention and the methods of treating the diseases mediated through muscarinic receptors.
    Type: Grant
    Filed: January 23, 2003
    Date of Patent: February 10, 2009
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Anita Mehta, Arundutt V. Silamkoti, Naresh Kumar, Jang Bahadur Gupta
  • LUT based multiplexers
    Patent number: 7486110
    Abstract: An improved LUT based multiplexer, including a first set of muxlets, each receiving a subset of input data lines at its inputs and one or more muxlet stages cascaded together to form a tree structure in which the roots are the first set of muxlets and the last stage of muxlet produces the final output.
    Type: Grant
    Filed: September 23, 2005
    Date of Patent: February 3, 2009
    Assignee: STMicroelectronics Pvt. Ltd.
    Inventors: Naresh Kumar Bhatti, Sonia Singhal
  • Muscarinic Receptor Antagonists
    Publication number: 20090012116
    Abstract: Provided are muscarinic receptor antagonists, which can be useful in treating various diseases of the respiratory, urinary or gastrointestinal system mediated through muscarinic receptors. Also provided are processes for preparing compounds described herein, pharmaceutical compositions comprising compounds described herein, and methods for treating diseases mediated through muscarinic receptors.
    Type: Application
    Filed: July 11, 2006
    Publication date: January 8, 2009
    Inventors: Naresh Kumar, Kirandeep Kaur, Sandeep Sinha, Suman Gupta, Venkata P. Palle, Anita Chugh
  • 3,6-Disubstituted Azabicyclo (3.1.0) Hexane Derivatives as Muscarinic Receptor Antagonists
    Publication number: 20080319043
    Abstract: The present invention generally relates to muscarinic receptor antagonists, which are useful, among other uses, for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to the process for the preparation of disclosed compounds, pharmaceutical compositions containing the disclosed compounds, and the methods for treating diseases mediated through muscarinic receptors.
    Type: Application
    Filed: May 1, 2006
    Publication date: December 25, 2008
    Inventors: Mohammad Salman, Naresh Kumar, Kirandeep Kaur, Shelly Aeron, Pakala Kumara Savithru Sarma, Sankaranarayanan Dharmarajan, Anita Mehta, Anita Chugh
  • Isoflavonoid Dimers
    Publication number: 20080306140
    Abstract: Novel compounds based on phenyl-substituted naphtho[1,2-g]chrysene compounds (A) are described. The compounds are obtainable by dimerisation of 3-phenylchroman (isoflavonoid) ring systems (B). Methods of synthesis of the novel dimeric compounds, compositions containing same and use of the dimers as therapeutic agents are also described.
    Type: Application
    Filed: March 24, 2006
    Publication date: December 11, 2008
    Applicant: NOVOGEN RESEARCH PTY LTD
    Inventors: Andrew Heaton, Naresh Kumar
  • Bioavailability enhancing activity of carum carvi extracts and fractions thereof
    Publication number: 20080292736
    Abstract: The present invention relates to the use of extracts of Carum carvi as bioenhancers, either alone or in combination with piperine or Zingiber officinale extract to improve the bioavailability of a wide variety of drugs.
    Type: Application
    Filed: January 28, 2008
    Publication date: November 27, 2008
    Inventors: Ghulam Nabi Qazi, Kasturi Lal Bedi, Rakesh Kamal Johri, Manoj Kumar Tikoo, Ashok Kumar Tikoo, Subhash Chandra Sharma, Tasaduaq Abdullah, Om Parkash Suri, Bishan Datt Gupta, Krishan Avtar Suri, Naresh Kumar Satti, Ravi Kant Khajuria
  • Azabicyclo derivatives as muscarinic receptor antagonists
    Patent number: 7446123
    Abstract: This invention generally relates to muscarinic receptor antagonists of formula (I) which are useful, among other uses for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to pharmaceutical compositions containing the compounds of the present invention and the methods of treating the diseases mediated through muscarinic receptors.
    Type: Grant
    Filed: January 7, 2004
    Date of Patent: November 4, 2008
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Mohammad Salman, Anita Mehta, Pakala Kumara Savithru Sarma, Naresh Kumar, Sankaranarayanan Dharmarajan, Kirandeep Kaur, Anita Chugh